170 related articles for article (PubMed ID: 29552790)
1. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma.
Bashir K; Sarwar R; Fatima S; Saeed S; Mahjabeen I; Akhtar Kayani M
J BUON; 2018; 23(1):234-243. PubMed ID: 29552790
[TBL] [Abstract][Full Text] [Related]
2. Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma.
Yan L; Li Q; Li X; Ji H; Zhang L
Cell Physiol Biochem; 2016; 38(3):1075-84. PubMed ID: 26938431
[TBL] [Abstract][Full Text] [Related]
3. Genetic Association of XRCC1 Gene rs1799782, rs25487 and rs25489 Polymorphisms with Risk of Thyroid Cancer: a Systematic Review and Meta-Analysis.
Jafari Nedooshan J; Forat Yazdi M; Neamatzadeh H; Zare Shehneh M; Kargar S; Seddighi N
Asian Pac J Cancer Prev; 2017 Jan; 18(1):263-270. PubMed ID: 28240845
[TBL] [Abstract][Full Text] [Related]
4. Interaction Between XRCC1 Gene Polymorphisms and Obesity on Susceptibility to Papillary Thyroid Cancer in Chinese Han Population.
Zhu J; Qi P; Li Z
Cell Physiol Biochem; 2018; 49(2):638-644. PubMed ID: 30165355
[TBL] [Abstract][Full Text] [Related]
5. Association between Polymorphisms of X-Ray Repair Cross Complementing Group 1 Gene and Pancreatic Cancer Risk: a Systematic Review with Meta-Analysis.
Chen J; Wang H; Li Z
Pathol Oncol Res; 2019 Jul; 25(3):897-904. PubMed ID: 29285737
[TBL] [Abstract][Full Text] [Related]
6. MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia.
Floris M; Sanna D; Castiglia P; Putzu C; Sanna V; Pazzola A; De Miglio MR; Sanges F; Pira G; Azara A; Lampis E; Serra A; Carru C; Steri M; Costanza F; Bisail M; Muroni MR
BMC Cancer; 2020 Mar; 20(1):234. PubMed ID: 32192442
[TBL] [Abstract][Full Text] [Related]
7. Single Nucleotide Polymorphisms in DNA Repair Genes (XRCC1, XRCC2, XRCC3) and Their Association with Radiotherapy Toxicity among Head and Neck Cancer Patients:A Study from South-Western Maharashtra.
Gudur AK; Gudur RA; Bhosale SJ; Kale SR; Datkhile KD
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3049-3057. PubMed ID: 37774056
[TBL] [Abstract][Full Text] [Related]
8. Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China: Effects of DNA repair genes polymorphisms on genetic damage.
Zhang GH; Ren JC; Luo M; Cui J; Du Y; Yang D; Cui S; Wang X; Wu W; Cao J; Xia ZL
Mutat Res Genet Toxicol Environ Mutagen; 2019 Mar; 839():13-20. PubMed ID: 30744808
[TBL] [Abstract][Full Text] [Related]
9. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis.
Ho T; Li G; Lu J; Zhao C; Wei Q; Sturgis EM
Thyroid; 2009 Feb; 19(2):129-35. PubMed ID: 19191745
[TBL] [Abstract][Full Text] [Related]
10. Association of XRCC1 polymorphisms with thyroid cancer risk.
Wang C; Ai Z
Tumour Biol; 2014 May; 35(5):4791-7. PubMed ID: 24477575
[TBL] [Abstract][Full Text] [Related]
11. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.
Kumar A; Pant MC; Singh HS; Khandelwal S
Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240
[TBL] [Abstract][Full Text] [Related]
12. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.
Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046
[TBL] [Abstract][Full Text] [Related]
13. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
[TBL] [Abstract][Full Text] [Related]
14. Association Between the XRCC1, GSTM1, and GSTT1 Polymorphisms in Model of Thyroid Cancer: A Meta-Analysis.
Yang W; Liu W; Zhu L; Lin Y; Meng Z; Wang Y
Horm Metab Res; 2023 Sep; 55(9):625-633. PubMed ID: 37678329
[TBL] [Abstract][Full Text] [Related]
15. The association between XRCC1 polymorphism and laryngeal cancer susceptibility in different ethnic groups in Xinjiang, China.
Alimu N; Qukuerhan A; Wang S; Abdurehim Y; Kuyaxi P; Zhang B; Yasheng Y
Int J Clin Exp Pathol; 2018; 11(9):4595-4604. PubMed ID: 31949858
[TBL] [Abstract][Full Text] [Related]
16. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
Bashir K; Sarwar R; Saeed S; Mahjabeen I; Kayani MA
PLoS One; 2018; 13(9):e0199007. PubMed ID: 30183716
[TBL] [Abstract][Full Text] [Related]
17. No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.
Gsur A; Bernhart K; Baierl A; Feik E; Führlinger G; Hofer P; Leeb G; Mach K; Micksche M
Cancer Epidemiol; 2011 Oct; 35(5):e38-41. PubMed ID: 21612998
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
[TBL] [Abstract][Full Text] [Related]
19. XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample.
Ryu RA; Tae K; Min HJ; Jeong JH; Cho SH; Lee SH; Ahn YH
J Korean Med Sci; 2011 Aug; 26(8):991-5. PubMed ID: 21860547
[TBL] [Abstract][Full Text] [Related]
20. Distribution and haplotype associations of XPD Lys751Gln, XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms with nasopharyngeal carcinoma in the Malaysian population.
Visuvanathan S; Chong PP; Yap YY; Lim CC; Tan MK; Lye MS
Asian Pac J Cancer Prev; 2014; 15(6):2747-51. PubMed ID: 24761895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
